|
⚲
|
| Baker Bros Advisors LP
✚
| |
|---|---|
| CRD # | 158149 |
| SEC # | 801-73446 |
| CIK # | 0001263508 |
| AUM | $22.0 BB (2024-03-28) |
| Employees | 52 (35% Investors, 0% Brokers) |
| Phone | 212-339-5600 |
| Address | 860 Washington Street, 3rd Floor New York, NY 10014 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($BB) |
|---|
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| INCY | 16.8 | 1.9 | |
| BGNE | 17.0 | 1.5 | |
| ACAD | 2.3 | 0.7 | |
| MDGL | 1.2 | 0.6 | |
| RVMD | 1.3 | 0.3 | |
| RYTM | 0.2 | 0.3 | |
| INSM | 2.4 | 0.2 | |
| BCYC | 0.5 | 0.2 | |
| SMMT | 0.1 | 0.2 | |
| KYMR | 1.0 | 0.2 | |
| View All | |||
| Holdings by Sector ($BB) |
|---|
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | 14159 LP | 2012-02-13 | 17.0 | |
| HF | 667 LP | 2012-02-13 | 1,516.6 | |
| HF | Baker Biotech Fund II A LP | 2012-02-13 | 9.4 | |
| HF | Baker Bros Investments II LP | 2012-02-13 | 1.2 | |
| HF | Baker Bros Investments LP | 2012-02-13 | 9.8 | |
| HF | Baker Brothers Life Sciences LP | [2012-02-13] | 0.0 | 20,459.6 |
| HF | Baker/Tisch Investments LP | 2012-02-13 | 11.0 |
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 22.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 2 | 22.0 |
| By Discretionary | ||
| Discretionary | 2 | 22.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 2 | 22.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 22.0 | |
| Total | 2 | 22.0 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 |
|---|---|---|---|
| General Partner Baker Brothers Life Sciences Capital LP | 14 | ||
| General Partner of The General Partner Baker Brothers Life Sciences Capital GP LLC | 10 |
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001263508] | |
| 3 | [0001263508] | |
| 4 | [0001263508] | |
| 5 | [0001263508] | |
| SC 13D | [0001263508] | |
| SC 13G | [0001263508] |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Towers Watson Investment Management Limited
✚
|
23.5 | |
|
Jacobs Levy Equity Management Inc
✚
|
NJ | 22.9 |
|
Pictet Asset Management Limited
✚
|
22.6 | |
|
Systematica Investments Limited
✚
|
22.3 | |
|
D E Shaw Investment Management LLC
✚
|
NY | 22.1 |
|
Alyeska Investment Group LP
✚
|
IL | 22.0 |
|
Aristotle Pacific Capital LLC
✚
|
CA | 21.9 |
|
Anchorage Capital Advisors LP
✚
|
NY | 21.6 |
|
Gabelli Funds LLC
✚
|
NY | 21.0 |
|
HBK Investments LP
✚
|
TX | 20.3 |